New Drugs

FDA Approves Opill (norgestrel) OTC Daily Oral Contraceptive

2 years ago
by David Miller
947 Views
Written by David Miller

DUBLIN, July 13, 2023 /PRNewswire/ — Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, announced today that the U.S. Food and Drug Administration (FDA) approved Opill®, a progestin-only daily oral…Original Article

You may also like

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

View all posts

Don`t Leave Yet!

Thank you!

[mwai_chat window="true" fullscreen="true"]